Table 1.
Gender: male/female (n) | 52 / 20 |
Age: years# | 33.8 (29.1–38.5) |
Patients with GERD symptoms >2 per week (n) | 15 |
Reflux Disease Questionnaire score+ | 3 (1–5) |
Patients previously using PPI regularly (n) | 0 |
Patients with endoscopic hiatal hernia (n) | 12 |
BEWE score+ | 14 (11–17) |
Median follow-up time+ | 1 (1–1) |
BEWE Basic erosive wear examination [7]. (9–13 medium, >13 extensive erosive disease), GERD gastrooesophageal reflux disease, PPI proton pump inhibitor. #means (95% confidence intervals) + median (interquartile range)